122 related articles for article (PubMed ID: 16265687)
41. Emerging biologic drugs for the treatment of rheumatoid arthritis.
Puppo F; Murdaca G; Ghio M; Indiveri F
Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
[TBL] [Abstract][Full Text] [Related]
42. B cell-directed therapy in rheumatoid arthritis--clinical experience.
Panayi GS
J Rheumatol Suppl; 2005 Feb; 73():19-24; discussion 29-30. PubMed ID: 15693112
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
Isaacs JD
Expert Opin Biol Ther; 2009 Dec; 9(12):1463-75. PubMed ID: 19916731
[TBL] [Abstract][Full Text] [Related]
44. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.
Salliot C; Finckh A; Katchamart W; Lu Y; Sun Y; Bombardier C; Keystone E
Ann Rheum Dis; 2011 Feb; 70(2):266-71. PubMed ID: 21097801
[TBL] [Abstract][Full Text] [Related]
45. What is the role of rituximab in the treatment of rheumatoid arthritis?
Atzeni F; Doria A; Turiel M; Sarzi-Puttini P
Autoimmun Rev; 2007 Sep; 6(8):553-8. PubMed ID: 17854748
[TBL] [Abstract][Full Text] [Related]
46. [Targeting CD20 in rheumatoid arthritis].
Saito K; Tanaka Y
Nihon Rinsho; 2007 Jul; 65(7):1243-9. PubMed ID: 17642239
[TBL] [Abstract][Full Text] [Related]
47. [The pulmonological manifestations of rheumatoid arthritis].
Bernscherer G; Karabélyos C; Tarján Z
Orv Hetil; 2008 Jul; 149(29):1355-61. PubMed ID: 18617467
[TBL] [Abstract][Full Text] [Related]
48. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
Choy E
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
[TBL] [Abstract][Full Text] [Related]
49. Management of rheumatoid arthritis.
Handa R
Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
[TBL] [Abstract][Full Text] [Related]
50. Tolerability and safety of rituximab (MabThera).
Kimby E
Cancer Treat Rev; 2005 Oct; 31(6):456-73. PubMed ID: 16054760
[TBL] [Abstract][Full Text] [Related]
51. Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade.
Manadan AM; Block JA
Am J Ther; 2008; 15(1):53-8. PubMed ID: 18223354
[TBL] [Abstract][Full Text] [Related]
52. Is there a need for new therapies for rheumatoid arthritis?
Fleischmann RM
J Rheumatol Suppl; 2005 Feb; 73():3-7; discussion 29-30. PubMed ID: 15693109
[TBL] [Abstract][Full Text] [Related]
53. Rituximab treatment of refractory rheumatoid arthritis.
Summers KM; Kockler DR
Ann Pharmacother; 2005 Dec; 39(12):2091-5. PubMed ID: 16249269
[TBL] [Abstract][Full Text] [Related]
54. B-cell therapies in established rheumatoid arthritis.
Leandro MJ; Becerra-Fernandez E
Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):535-48. PubMed ID: 22137923
[TBL] [Abstract][Full Text] [Related]
55. Current aspects of anti-CD20 therapy in rheumatoid arthritis.
Jacobi AM; Dörner T
Curr Opin Pharmacol; 2010 Jun; 10(3):316-21. PubMed ID: 20189875
[TBL] [Abstract][Full Text] [Related]
56. [B-cell depletion in the treatment of rheumatoid arthritis].
Feist E; Burmester GR; Dörner T
Z Rheumatol; 2003 Aug; 62(4):361-6. PubMed ID: 12928940
[TBL] [Abstract][Full Text] [Related]
57. [Infliximab].
Yoshida N; Hashimoto T; Atsumi T; Koike T
Nihon Rinsho; 2007 Jul; 65(7):1251-8. PubMed ID: 17642240
[TBL] [Abstract][Full Text] [Related]
58. Review on the influence of protocol design on clinical outcomes in rheumatoid arthritis treated with rituximab.
Shetty S; Fisher MC; Ahmed AR
Ann Pharmacother; 2013 Mar; 47(3):311-23. PubMed ID: 23447479
[TBL] [Abstract][Full Text] [Related]
59. Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis.
Hainsworth JD
Arthritis Res Ther; 2003; 5 Suppl 4(Suppl 4):S12-6. PubMed ID: 15180892
[TBL] [Abstract][Full Text] [Related]
60. Targeting the B cell in rheumatoid arthritis.
Cohen SB
Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):553-63. PubMed ID: 20732652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
